esophageal cancer Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers Researchers found four esophageal squamous cell carcinoma molecular subtypes by generating genomic, transcriptomic, epigenetic, and proteomic profiles for more than 150 cases. ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets. Castle Bio Q2 Growth Driven by Skin Cancer Testing as New Acquisitions Boost Sales Premium The company reported a record number of tests in the quarter led by its skin cancer menu but with notable sales in other test categories. Immuno-Genomic Features Predict Treatment Response in Esophageal Carcinoma Researchers developed a machine learning tool that combines the features to predict response to platinum-based neoadjuvant chemotherapy. QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International Under the agreement, Proteomics International has the right to use the markers to develop and commercialize a blood-based early detection test for esophageal cancer. May 9, 2022 Castle Biosciences Q1 Revenues Grow 18 Percent Mar 31, 2022 New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch Premium Mar 29, 2022 Lucid Diagnostics Reports $300K in Preliminary Q4 Revenues Mar 3, 2022 Lucid Diagnostics Acquires Laboratory Assets From ResearchDx for $6.2M Mar 2, 2022 Castle Bio Adds Data for DecisionDx Melanoma Assay, Eyes Squamous Cell Carcinoma Reimbursement Premium Feb 28, 2022 Castle Biosciences Q4 Revenues Grow 45 Percent Nov 17, 2021 Newly Public Lucid Diagnostics Posts $200K in Preliminary Q3 Revenues Nov 8, 2021 BTIG, Canaccord Genuity Initiate Coverage of Lucid Diagnostics With Buy Ratings Oct 27, 2021 Castle Biosciences Buy of Cernostics Aligns With Goal to Diversify Portfolio Premium Oct 19, 2021 Castle Biosciences Acquires Cernostics for up to $80M Oct 14, 2021 Lucid Diagnostics Prices $70M IPO, Starts Trading on Nasdaq Jul 13, 2021 Gastric Cancer Cases Frequently Harbor Genetic Risk Variants, Suggesting Germline Testing Jun 10, 2021 Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test Feb 18, 2021 Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers Oct 12, 2020 Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 8, 2020 Early Copy Number Changes Predict Progression of Barrett's Esophagus to Esophageal Cancer Aug 6, 2020 PavMed Raises $7M in Private Funding Round Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Premium May 11, 2020 Genetic Ancestry Linked to Differences in Molecular Features of Cancers Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.